// App-Quantinova.ai

: High Expression of CXCR4 - CXCR7 - CXCL12 Predicts Poor Survival after Up-Front Resection of Pancreatic Adenocarcinoma

Researchers

Presenter

  • A. Giardino

Principal Investigators

  • C. D'Alterio

  • S. Scala

  • I. Frigerio

  • R. Girelli

  • P. Regi

  • F. Scopelliti

  • V. Allegrini

  • G. Butturini

Medical Centers

  • Pascale Institute, Functional Genomics, Napoli (NA), Italy

  • Pederzoli Hospital, HPB Unit, Peschiera del Garda (VR), Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Microphthalmia, syndromic, 9

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • CXCL12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved